Streetbeat News

Regulatory

NJR

New Jersey Natural Gas (NJNG), a business of New Jersey Resources (NJR), has filed with the New Jersey Board of Public Utilities to extend its current SAVEGREEN energy-efficiency offerings for an additional six months through December 31, 2024. NJNG is seeking approval to invest up to $76 million to cover the program offerings during the extension period. This is in addition to the $259 million previously approved for the current three-year cycle.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 11:58 pm

FEAM

5E Advanced Materials, Inc. (NASDAQ:FEAM) has entered a standstill agreement with its primary lender, BEP Special Situations IV, LLC, to facilitate discussions for a funding solution for the next phase of operations. The agreement allows 5E to go below its current cash covenant until December 1, 2023. The company has also retained Province to advise in restructuring its debt. The CEO stated that a successful restructure of convertible notes and approval from the EPA will enable the company to advance operations and growth.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 11:56 pm

DBVT

DBV Technologies has announced positive interim results from its ongoing Phase 3 Open-Label Extension to the EPITOPE Trial of Viaskin Peanut in toddlers. The treatment showed improvement across all efficacy parameters between months 12 and 24. Notably, 81.3% of subjects reached an eliciting dose of ≥1,000 mg after 24 months of treatment. There were no treatment-related anaphylactic or serious treatment-related adverse events in the second year of active treatment. The company will present these results at the American College of Allergy, Asthma, and Immunology annual meeting.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 11:46 pm

AEY

ADDvantage Technologies Group, Inc. (NASDAQ:AEY) has announced a 1-for-10 reverse stock split of its common stock as part of its Nasdaq compliance plan. The reverse stock split is expected to take effect on November 16, 2023. No fractional shares will be issued, instead, stockholders will receive cash in lieu of fractional shares. The number of outstanding shares will be reduced from approximately 14,947,078 to approximately 1,494,707 after the reverse stock split.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 11:45 pm

BTCUSD

Regulators are increasingly introducing legislation around crypto assets, leading to a rise in cryptocurrency compliance. This is crucial in preventing fraud in a sector known for its volatility and scams. Several firms, including TRM Labs, Scorechain, Solidus Labs, AMLT Network, BitFury, DigiShares, Chainalysis and Elliptic, offer compliance services for cryptocurrency operations.

Portfolio Pulse from Tanzeel Akhtar

November 09, 2023 | 11:41 pm

BTCUSD

ETHUSD

Ethereum's price crossed the $2,000 mark for the first time since July 2023 after BlackRock Advisors registered an iShares Ethereum Trust in Delaware. The price increase was accompanied by a surge in trading volume of 259% and a market cap increase of over 10%. This comes as the SEC opens the window to issue approval orders for all 12 spot Bitcoin ETF applications. The global crypto market capitalization stands at $1.38 trillion, a 2.3% increase from the previous day.

Portfolio Pulse from Khyathi Dalal

November 09, 2023 | 11:10 pm

HTGC

Hercules Capital, Inc. (NYSE:HTGC) has received a 'green light' letter from the U.S. Small Business Administration (SBA) to submit an application for a fourth Small Business Investment Company (SBIC) license. If approved, Hercules would gain access to an additional $175 million of long-term debentures, increasing its total borrowing capacity through the SBIC program to $350 million. However, the receipt of the letter does not guarantee the issuance of the license.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 10:45 pm

SANA

Sana Biotechnology, Inc. (NASDAQ:SANA) has received FDA clearance for its Investigational New Drug (IND) application to initiate a study of SC291, a hypoimmune-modified, CD19-directed allogeneic CAR T therapy, for patients with multiple B-cell mediated autoimmune diseases. The company plans to begin treating patients soon and expects to disclose initial safety and efficacy data in 2024.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 10:28 pm

BLK

COIN

BlackRock Inc. has submitted a form 19b-4, indicating its plans to launch an Ether exchange-traded fund (ETF). The firm plans to use Coinbase Custody Trust Company's services to safeguard the proposed ETF's holdings. The ETF would be benchmarked against the CME CF Ether-Dollar Reference Rate - New York Variant. This move aligns with BlackRock's efforts to introduce a Bitcoin ETF and reflects a broader trend of integrating cryptocurrencies into traditional investment portfolios.

Portfolio Pulse from Murtuza Merchant

November 09, 2023 | 10:23 pm

LYEL

Lyell Immunopharma, Inc. (NASDAQ:LYEL) has received FDA Orphan Drug Designation for LYL845, a product candidate for the treatment of stage IIB-IV melanoma. The designation provides certain incentives, including tax credits for qualified clinical trials and potential seven-year marketing exclusivity upon FDA approval. LYL845 is currently being investigated in a Phase 1 clinical trial in patients with advanced melanoma, non-small cell lung cancer, and colorectal cancer. Initial data from the trial are expected in 2024.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 10:22 pm